Lista de obras -

A case of prostatic adenocarcinoma with aberrant p63 expression: presentation with detailed immunohistochemical study and FISH analysis.

artículo científico publicado en 2010

A non-coding RNA balancing act: miR-346-induced DNA damage is limited by the long non-coding RNA NORAD in prostate cancer

artículo científico publicado en 2022

Assessing the order of critical alterations in prostate cancer development and progression by IHC: further evidence that PTEN loss occurs subsequent to ERG gene fusion

artículo científico publicado en 2013

Association between Serum Phospholipid Fatty Acids and Intraprostatic Inflammation in the Placebo Arm of the Prostate Cancer Prevention Trial.

artículo científico publicado en 2015

Benign mixed epithelial and stromal tumor of the kidney.

artículo científico publicado en 2006

Can telomere alterations predict biochemical recurrence in prostate adenocarcinoma? A preliminary study

artículo científico publicado en 2010

Chronic inflammation in benign prostate tissue is associated with high-grade prostate cancer in the placebo arm of the prostate cancer prevention trial

artículo científico publicado en 2014

Comparative Proteome Analysis of Breast Cancer Tissues Highlights the Importance of Glycerol-3-phosphate Dehydrogenase 1 and Monoacylglycerol Lipase in Breast Cancer Metabolism

artículo científico publicado en 2019

DNA hypomethylation arises later in prostate cancer progression than CpG island hypermethylation and contributes to metastatic tumor heterogeneity.

artículo científico publicado en 2008

Effect of Preanalytic Variables on an Automated PTEN Immunohistochemistry Assay for Prostate Cancer

artículo científico publicado en 2018

Effects of Ginkgo biloba extract on spinal cord ischemia-reperfusion injury in rats

artículo científico publicado en 2014

Genomic Analysis of Three Metastatic Prostate Cancer Patients with Exceptional Responses to Carboplatin Indicating Different Types of DNA Repair Deficiency

article

Genomics of lethal prostate cancer at diagnosis and castration resistance

artículo científico publicado en 2020

Global levels of H3K27me3 track with differentiation in vivo and are deregulated by MYC in prostate cancer.

artículo científico publicado en 2012

HER3 Is an Actionable Target in Advanced Prostate Cancer

artículo científico publicado en 2021

High expression of prostate-specific membrane antigen in the tumor-associated neo-vasculature is associated with worse prognosis in squamous cell carcinoma of the oral cavity.

artículo científico publicado en 2012

Inflammation in Benign Prostate Tissue and Prostate Cancer in the Finasteride Arm of the Prostate Cancer Prevention Trial.

artículo científico publicado en 2015

Intraprostatic inflammation is positively associated with serum PSA in men with PSA <4 ng ml(-1), normal DRE and negative for prostate cancer

artículo científico publicado en 2015

JMJD6 Is a Druggable Oxygenase That Regulates AR-V7 Expression in Prostate Cancer

artículo científico publicado en 2021

Langerhans' cell histiocytosis mimicking metastatic carcinoma of the lung.

artículo científico publicado en 2009

Molecular alterations in prostate cancer as diagnostic, prognostic, and therapeutic targets

artículo científico publicado en 2008

Molecular evidence that invasive adenocarcinoma can mimic prostatic intraepithelial neoplasia (PIN) and intraductal carcinoma through retrograde glandular colonization

artículo científico publicado en 2015

More than Ophelia syndrome: Multiple paraneoplastic syndromes in pediatric Hodgkin lymphoma

artículo científico publicado en 2019

NKX3.1 as a marker of prostatic origin in metastatic tumors.

artículo científico publicado en 2010

Olaparib in patients with metastatic castration-resistant prostate cancer with DNA repair gene aberrations (TOPARP-B): a multicentre, open-label, randomised, phase 2 trial

scientific article published on 02 December 2019

PTEN loss and chromosome 8 alterations in Gleason grade 3 prostate cancer cores predicts the presence of un-sampled grade 4 tumor: implications for active surveillance.

artículo científico publicado en 2016

Preventive effect of aminoguanidine compared to vitamin E and C on cisplatin-induced nephrotoxicity in rats.

artículo científico publicado en 2008

Prostate-specific Membrane Antigen Heterogeneity and DNA Repair Defects in Prostate Cancer

scientific article published on 22 July 2019

Scoring Idiopathic Granulomatous Mastitis: An Effective System for Predicting Recurrence?

artículo científico publicado en 2018

Targeting the p300/CBP Axis in Lethal Prostate Cancer

artículo científico publicado en 2021

Lista de obras de

A case of prostatic adenocarcinoma with aberrant p63 expression: presentation with detailed immunohistochemical study and FISH analysis.

A non-coding RNA balancing act: miR-346-induced DNA damage is limited by the long non-coding RNA NORAD in prostate cancer

Assessing the order of critical alterations in prostate cancer development and progression by IHC: further evidence that PTEN loss occurs subsequent to ERG gene fusion

Association between Serum Phospholipid Fatty Acids and Intraprostatic Inflammation in the Placebo Arm of the Prostate Cancer Prevention Trial.

Benign mixed epithelial and stromal tumor of the kidney.

Can telomere alterations predict biochemical recurrence in prostate adenocarcinoma? A preliminary study

Chronic inflammation in benign prostate tissue is associated with high-grade prostate cancer in the placebo arm of the prostate cancer prevention trial

Comparative Proteome Analysis of Breast Cancer Tissues Highlights the Importance of Glycerol-3-phosphate Dehydrogenase 1 and Monoacylglycerol Lipase in Breast Cancer Metabolism

DNA hypomethylation arises later in prostate cancer progression than CpG island hypermethylation and contributes to metastatic tumor heterogeneity.

Effect of Preanalytic Variables on an Automated PTEN Immunohistochemistry Assay for Prostate Cancer

Effects of Ginkgo biloba extract on spinal cord ischemia-reperfusion injury in rats

Genomic Analysis of Three Metastatic Prostate Cancer Patients with Exceptional Responses to Carboplatin Indicating Different Types of DNA Repair Deficiency

Genomics of lethal prostate cancer at diagnosis and castration resistance

Global levels of H3K27me3 track with differentiation in vivo and are deregulated by MYC in prostate cancer.

HER3 Is an Actionable Target in Advanced Prostate Cancer

High expression of prostate-specific membrane antigen in the tumor-associated neo-vasculature is associated with worse prognosis in squamous cell carcinoma of the oral cavity.

Inflammation in Benign Prostate Tissue and Prostate Cancer in the Finasteride Arm of the Prostate Cancer Prevention Trial.

Intraprostatic inflammation is positively associated with serum PSA in men with PSA <4 ng ml(-1), normal DRE and negative for prostate cancer

JMJD6 Is a Druggable Oxygenase That Regulates AR-V7 Expression in Prostate Cancer

Langerhans' cell histiocytosis mimicking metastatic carcinoma of the lung.

Molecular alterations in prostate cancer as diagnostic, prognostic, and therapeutic targets

Molecular evidence that invasive adenocarcinoma can mimic prostatic intraepithelial neoplasia (PIN) and intraductal carcinoma through retrograde glandular colonization

More than Ophelia syndrome: Multiple paraneoplastic syndromes in pediatric Hodgkin lymphoma

NKX3.1 as a marker of prostatic origin in metastatic tumors.

Olaparib in patients with metastatic castration-resistant prostate cancer with DNA repair gene aberrations (TOPARP-B): a multicentre, open-label, randomised, phase 2 trial

PTEN loss and chromosome 8 alterations in Gleason grade 3 prostate cancer cores predicts the presence of un-sampled grade 4 tumor: implications for active surveillance.

Preventive effect of aminoguanidine compared to vitamin E and C on cisplatin-induced nephrotoxicity in rats.

Prostate-specific Membrane Antigen Heterogeneity and DNA Repair Defects in Prostate Cancer

Scoring Idiopathic Granulomatous Mastitis: An Effective System for Predicting Recurrence?

Targeting the p300/CBP Axis in Lethal Prostate Cancer